Study of the interaction of dithranol with heptakis(2,3,6-tri-O-methyl)-β-cyclodextrin in solution and in the solid state

Journal of Pharmacy and Pharmacology

Volumn 50, Issue 3, 1998, Pages 257-264

  Cafaggi, Sergio ^a   Vallarino, Marisa ^a   Caviglioli, Gabriele ^a   Parodi, Brunella ^a   Bignardi, Gaetano ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; BETA CYCLODEXTRIN DERIVATIVE; DITHRANOL; HEPTAKIS(2,3,6 O TRIMETHYL) BETA CYCLODEXTRIN; ISOASCORBIC ACID; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DEGRADATION; DRUG MIXTURE; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; SOLID; X RAY POWDER DIFFRACTION;

EID: 0031939844     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1998.tb06858.x     Document Type: Article

References (27)

1. Abdel Rahman, A. A., Saleh, S. I., Nakai, Y., Aboutaleb, A. E., Ahmed, M. O. (1993) Inclusion complexation between trimethyl-β-cyclodextrin and clobazam or flunitrazepam during sealed heating. Eur. J. Pharm. Biopharm. 39: 82-86
2. August, J. (1989) The choice of topical steroids-a personal view. Acta Derm. Venereol. 151 (Suppl.): 31-36
3. Cavey, D., Caron, J. C., Shroot, B. (1982) Anthralin: chemical instability and glucose-6-phosphate dehydrogenase inhibition. J. Pharm. Sci. 71: 980-983
4. Cheah, I. C. L., Sitaram, B. R., Pappas, A., Thi, N. L., Finnin, B. C., Reed, B. L. (1989) Normal-phase and reversed-phase liquid chromatographic techniques for the determination of dithranol and its degradation products. J. Chromatogr. 467: 414-422
5. Chiou, W. L., Riegelman, S. (1971) Pharmaceutical applications of solid dispersion systems. J. Pharm. Sci. 60: 1281-1302
6. Delneuville, I., Windal, I., Ghitti, G., Fiorentina, H., Pauw, E., Delattre, L. (1996) Elimination of residual methylene chloride from a dithranol-polyvinylpyrrolidone coevaporate. J. Pharm. Belg. 51: 109-111
7. Ford, J. L. (1986) The current status of solid dispersions. Pharm. Acta Helv. 61: 69-88
8. Ford, J. L., Timmins, P. (1989) Pharmaceutical Thermal Analysis: Techniques and Applications. Ellis Horwood, pp 38-42
9. Gehring, W., Ghyczy, M., Gloor, M., Scheer, T., Röding, J. (1992) Enhancement of the penetration of dithranol and increase of effect of dithranol on the skin by liposomes. Arzneim. Forsch. 42: 983-985
10. Gehring, W., Ghyczy, M., Gareiss, J., Gloor, M. (1995) The influence on skin penetration by dithranol formulated in phospholipid solutions and phospholipid liposomes. Eur. J. Pharm. Biopharm. 41: 140-142
11. Higuchi, T., Connors, K. A. (1965) Phase solubility techniques. Adv. Anal. Chem. Instrum. 4: 117-212
12. Hiller, C., Campbell, C., Smeaton, I. (1995) How stable is dithranol? An investigation into the degradation of different dithranol formulations. Pharm. Pract. 5: 428-431
13. Kaneniwa, N., Ikekawa, A., Sumi, M. (1978) A decrease in crystallinity of amobarbital by mechanical treatment in the presence of the diluents. Chem. Pharm. Bull. 26: 2734-2743
14. Kahn, K. A. (1975) The concept of dissolution efficiency. J. Pharm. Pharmacol. 27: 48-49
15. Lach, J. L., Cohen, J. (1963) Interaction of pharmaceuticals with schardinger dextrins II. Interaction with selected compounds. J. Pharm. Sci. 52: 137-142
16. Loftsson, T., Brewster, M. E. (1996) Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85: 1017-1025
17. Loftsson, T., Frioriksdottir, H., Stefansson, E., Thorisdottir, S., Guomundsson, O., Sigthorsson, T. (1994) Topically effective ocular hypotensive acetazolamide and ethoxyzolamide formulations in rabbits. J. Pharm. Pharmacol. 46: 503-504
18. Mustakallio, K. K. (1981) Irritation, staining and antipsoriatic activity of 10-acyl analogue of anthralin. Br. J. Dermatol. 105 (Suppl. 20): 23-27
19. Nakai, Y., Fukuoka, E., Nakajima, S., Yamamoto, K. (1977) Effects of grinding on physical and chemical properties of crystalline medicinals with microcrystalline cellulose. I. Some physical properties of crystalline medicinals in ground mixtures. Chem. Pharm. Bull. 25: 3340-3346
20. Nakai, Y., Yamamoto, K., Terada, K., Horibe, H. (1984) Interaction of tri-O-methyl-β-cyclodextrin with drugs. J. Incl. Phenom. 2: 523-530
21. Nakai, Y., Yamamoto, K., Terada, K., Watanabe, D. (1987) New methods for preparing cyclodextrins inclusion compounds. I. Heating in a sealed container. Chem. Pharm. Bull. 35: 4609-4615
22. Nogami, H., Nagai, T., Yotsuyanagi, T. (1969) Dissolution phenomena of organic medicinals involving simultaneous phase changes. Chem. Pharm. Bull. 17: 499-509
23. Preiss, A., Mehnert, W., Fromming, K. H. (1994) In vitro hydrocortisone release from ointments in presence of cyclodextrins. Pharmazie 49: 902-906
24. Segal, A., Katz, C., Van Duuren, B. L. (1971) Structure and tumor-promoting activity of anthralin (1,8-dihydroxy-9-anthrone) and related compounds. J. Med. Chem. 14: 1152-1154
25. Vollmer, U., Muller, B. W., Peeters, J., Mesens, J., Wilffert, B., Peters, T. (1994) A study of the percutaneous absorption-enhancing effects of cyclodextrin derivatives in rats. J. Pharm. Pharmacol. 46: 19-22
26. Weller, P. J., Newman, C. M., Middleton, K. R., Wicker, S. M. (1990) Stability of a novel dithranol ointment formulation, containing ascorbyl palmitate as an anti-oxidant. J. Clin. Pharm. Ther. 15: 419-423
27. Wurster, D. E., Taylor, P. W. (1965) Dissolution kinetics of certain crystalline forms of prednisolone. J. Pharm. Sci. 54: 670-676